Millennium Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-25,000
Closed -$1.96M 4259
2015
Q1
$1.96M Buy
+25,000
New +$1.55M ﹤0.01% 1963

Other funds holding OREX

Millennium Management's OREX Position: Q2 2018 in Review

Millennium Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 14,130 shares — an estimated $3K sold.

Millennium Management first reported a position in OREX in Q2 2013 and held it in 15 quarters. The position peaked at $23M in Q2 2015. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Millennium Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Millennium Management sold 14,130 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $3K.
  • Millennium Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 15 quarters.
  • Millennium Management's Orexigen Therapeutics, Inc. position peaked at $23M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.